💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Aetna, Humana upgraded at Credit Suisse on brighter prospects under Trump

Published 11/11/2016, 12:07 PM
Aetna, Humana upgraded at Credit Suisse on brighter prospects under Trump
CSGN
-
AET
-
HUM
-
  • Aetna (AET +0.4%) and Humana (HUM +0.4%) are upgraded to Outperform from Neutral at Credit Suisse (SIX:CSGN), which says a Trump administration may improve prospects for health care stocks in general and also increase the chances that AET's pending deal to buy HUM would pass muster with antitrust officials.
  • The firm also says prospects for Medicare Advantage appear “particularly bright,” while there is uncertainty around the stocks of companies that are highly leveraged to the Affordable Care Act as a driver of their growth stories, particularly hospitals and Medicaid MCOs.
  • Credit Suisse raises its stock price target for AET to $135 from $120 and for HUM to $210 from $170.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.